Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Aldehyde Inhibitor
25%
Aldehydes
25%
Amino Acid Side Chain
25%
Carbonyl Group
25%
Cathepsin L
50%
Causative Agents
25%
CoV-2
100%
COVID-19
50%
Cysteine Protease Inhibitor
25%
Dual Inhibitor
100%
Dual-acting Inhibitor
25%
Dual-target Inhibitors
50%
EC50
25%
Glutamine
100%
Heteroatom
25%
Human Cathepsins
100%
Human Cells
25%
Hydrogen Bond (H-bond)
25%
Hydrogen Bonding Interaction
25%
Hydrophobic Amino Acids
25%
Inactivating mutation
25%
Indole
25%
Inhibition Constant
25%
Isostere
100%
Leucine
25%
Main Protease
25%
Multi-target
50%
New Inhibitors
25%
Nirmatrelvir
25%
Partial Preferences
25%
Peptide Scaffold
25%
Peptidomimetic Inhibitors
25%
Peptidomimetics
50%
Pfizer
25%
Phenylalanine
25%
Protease
75%
Protein Maturation
25%
Pyridinyl
50%
Resistance Development
25%
SARS-CoV-2 3CL Protease
100%
Scaffold-based
25%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
25%
Target-based Approach
25%
Viral
25%
Viral Infection
25%
Viral Protease
50%
Viral Proteins
25%
X-ray Structure
25%
Pharmacology, Toxicology and Pharmaceutical Science
Alanine
42%
Aldehyde
28%
Amino Acid
28%
Carbonyl Derivative
14%
Cathepsin L
100%
Cysteine Proteinase
14%
EC50
14%
Glutamine
100%
Hydrogen
14%
Hydrogen Bond
14%
Indole
14%
Infection
14%
Leucine
14%
Nirmatrelvir
14%
Nitrogen
14%
Peptide
14%
Peptidomimetics
42%
Phenylalanine
14%
Proteinase
100%
Proteinase Inhibitor
14%
SARS Coronavirus
100%
Viral Protein
14%
Virus Infection
14%